clorotepine

0 marketed 1 in Phase 2

This page covers all clorotepine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 6, D(4) dopamine receptor, 5-hydroxytryptamine receptor 2C.

Targets

5-hydroxytryptamine receptor 6, D(4) dopamine receptor, 5-hydroxytryptamine receptor 2C

Phase 2 pipeline (1)

Patent intelligence